Small-Caps With Catalysts This Week

We've reviewed numerous filings and press releases to highlight the catalysts for this upcoming week. Dive into our research and remember—staying ahead is key!

--

TRNR > Announced its 2025 exhibition season will begin with a fireside chat featuring Sweatworks' Mohammed Iqbal at LA's Connected Health & Fitness Summit (Feb 11-13), highlighting 2025 plans and an update on its next potential acquisition.

NRXP > Jonathan Javitt, CEO of NRx Pharmaceuticals, will present a company update at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12.

GLTO > The company announced its management team will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference, featuring a corporate presentation and one-on-one meetings on Wednesday, February 12, from 8:40 to 9:10 AM.

SGD > The company's subsidiary, LV Peninsula Holding LLC, has reached a $6.575M agreement with Lithe Development Inc. to sell its Lago Vista project at 1900 American Drive, Lago Vista, Texas. Signed on January 30, 2025, the deal is expected to close by February 12, 2025, pending final approvals and financing.

SCPH > John Tucker, President & Chief Executive Officer, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12 at 2:40PM ET.

QNCX > Dirk Thye, M.D., CEO and CMO of Quince, will join a fireside chat at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 2:00 p.m. ET.

LSTA > David J. Mazzo, PhD, CEO of Lisata, will present a corporate overview at the 2025 BIO CEO & Investor Conference, held February 10-11, 2025, at the New York Marriott Marquis.

GANX > Gene Mack, CEO of Gain, will present at two upcoming investor conferences: the BIO CEO & Investor Conference on February 11 at 1:15 p.m. ET at the New York Marriott Marquis, and the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12 at 10:40 a.m. ET in a virtual session. Investors can schedule one-on-one meetings with Gain management through the respective conference platforms.

FBLG > The company will host an in-person analyst day on February 12, 2025, at 2:00 p.m. ET at the New York Marriott Marquis. Presentations will include CEO Pete O'Heeron, CSO Hamid Khoja, PhD, and Interim CFO Robert Hoffman, focusing on FibroBiologics' R&D strategy for fibroblast-based therapeutics targeting chronic diseases.

CARM > Steven Kelly, President and Chief Executive Officer, will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11 at 4:40 pm ET.

CANF > Can-Fite will present at the BIO CEO & Investor Conference on February 10, 2025, at 3:45 p.m. EST at the New York Marriott Marquis. CEO and CFO Motti Farbstein will lead the presentation, with the management team holding one-on-one meetings to discuss business strategy, clinical milestones, and upcoming plans.

AXIL > AXIL will showcase its new MX Series hearing protection and "X Series" earplugs at the NASCAR Daytona 500 from February 13-16, 2025, at Daytona International Speedway.

ADVM > The company will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, at 4:40 p.m. ET.

WAVE > The company will participate in India Energy Week 2025 (Feb 11-14, New Delhi), showcasing its wave energy technology and signing a pilot project collaboration with a Fortune 500 Indian company in Maharashtra.

RVPH > Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva, will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025. He will also participate in a panel discussion, "Tackling Mental Health through New Targets and Endpoints Progress," at the BIO CEO & Investor Conference in New York on February 11, 2025.

QTTB > Management will participate in a virtual company presentation at 4:00 p.m. E.T. on Tuesday, February 11, 2025 at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.

PLX > The company will present a corporate overview at the 2025 BIO CEO & Investor Conference on February 11 at 10:15 AM EST in the Royale Room, New York Marriott Marquis. Management will also hold one-on-one meetings with investors, with the presentation available afterward on the company’s website.

LTRX > Lantronix will debut its LM4 AI-powered Out-of-Band Management platform at Stand A10 during Cisco Live, February 10–14, 2025, at Amsterdam RAI. Designed for compact environments like IDFs, ATMs, and kiosks, the LM4 offers enterprise-grade automation, compliance, and cybersecurity for industries such as healthcare, finance, telecom, and manufacturing.

JSPR > Management will present at the Oppenheimer Healthcare Life Sciences Conference, taking place February 11-12, 2025.

CLYM > The executive team will participate in the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, with a presentation at 9:20 a.m. ET and one-on-one investor meetings.

TARA > Management will participate in a virtual fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 12:40 pm ET.

VMAR > Vision Marine will exhibit at the Miami International Boat Show from February 14-18, 2024, showcasing its products at the Nautical Ventures Electric Pavilion in Pride Park, near the renowned AquaZone™.

ONDS > Chairman and CEO Eric Brock will present at TD Cowen's 46th Annual Aerospace & Defense Conference on February 12, 2025, at 9:15 a.m. ET at The Ritz-Carlton, Pentagon City. His presentation will highlight Ondas Autonomous Systems' critical defense and security platforms.

IMRX > CEO Ben Zeskind and CSO Brett Hall will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, from 2:40–3:10 p.m. ET, discussing the company’s pipeline, platform, and business strategy.

CALC > Rachel Leheny, Ph.D., Chief Executive Officer, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 8:00 a.m. ET.

AZTR > The company will present at the BIO CEO & Investor Conference on February 10, 2025, at 3:45 p.m. ET in the Royale Room at the New York Marriott Marquis. COO Travis Whitfill will lead the presentation.

SABS > The management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, from 10:00–10:30 a.m. ET.

INO > Dr. Jacqueline Shea, INOVIO's President and CEO, and Dr. Michael Sumner, CMO, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, from 3:20–3:50 p.m. ET. They will also hold one-on-one meetings with registered investors.

ANTX > Eric Easom, Co-Founder, Chairman, President, and CEO, will present a corporate overview at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, at 3:20 p.m. ET.

CLSD > George Lasezkay, PharmD, JD, President and CEO, and Victor Chong, MD, MBA, CMO and EVP, will participate in a Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference on February 11, 2025, at 9:20 a.m. ET. Additionally, Dr. Thomas A. Ciulla, Chief Medical Advisor-Retina, will present top-line results from the ODYSSEY Phase 2b study at The Macula Society 48th Annual Meeting, February 12-15, 2025.

LAES > SEALSQ will host Quantum Day at NASDAQ on February 11, 2025, featuring a roundtable on U.S. technological sovereignty following the closing bell. The discussion will focus on the need for innovation in semiconductors, post-quantum AI, and cybersecurity for national security and economic growth, addressing challenges and opportunities in building a secure U.S. semiconductor ecosystem.

ICAD > iCAD will attend the BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah, from February 11-12, 2025. CEO Dana Brown and CFO Eric Lonnqvist will hold one-on-one meetings with investors. Investors can request a meeting through their BTIG representative.

ENTX > The company will participate in the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025. CEO Miranda Toledano will present a business overview on February 11, from 12:40-1:10 p.m. ET.

CLRB > Members of the management team will present a company overview at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 12:00 p.m. ET.

TNXP > Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present at the BIO CEO & Investor Conference on February 10, 2025, at 1:45 p.m. ET in New York City.

PYPD > The company will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025. The presentation will be available on-demand starting February 12 at 11:20 a.m. ET.

CMMB > CEO Dr. Adi Mor and senior management will present and hold one-on-one investor meetings at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11, 2025.

VOR > The company will join a fireside chat and host virtual one-on-one investor meetings at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, at 12:00 p.m. ET.

COYA > CEO Arun Swaminathan, Ph.D., will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11, 2025, from 10:00–10:30 a.m. ET (Track 3).

IMAB > I-Mab's management will participate in the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025, with a presentation on February 11 from 4:00–4:30 p.m. ET.

IMUX > Immunic announced its participation in the BIO CEO & Investor Conference on February 10-11 in New York and the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12. CEO Dr. Daniel Vitt will hold a fireside chat on February 12 at 1:20 p.m. ET, with a webcast available on the company’s website. Key team members will also join one-on-one meetings at both events.

LCTX > Brian M. Culley, Lineage's Chief Executive Officer, will be presenting at the Oppenheimer 35th Annual Healthcare Lifesciences Conference on February 11, 2025 at 12:40pm ET. The conference is being held virtually February 11-12, 2025.

RGLS > members of the management team will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11th at 2:40 p.m. ET.

SNSE > John Celebi, President and Chief Executive Officer, will present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference, being held virtually, on Tuesday, February 11, 2025 at 10:40 a.m. ET.

VERU > Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present at the upcoming virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 12:00 pm – 12:30 pm ET.

OVID > Management will participate in a virtual presentation at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 4:00 p.m. ET.

VTYX > The company announced its executives will participate in the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, from 2:40-3:10 PM ET.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.